ARTICLE SYNOPSIS...Pulte Homes forged a classic retracement but cannot follow through on a bullish candlestick reversal, and lower prices are likely.
ARTICLE SYNOPSIS...The roof caved in for Inspire in early February when the pharmaceutical company indicated that the FDA had rejected its drug Diquafosol.